Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock

NCT01523717 is registered in ClinicalTrials.gov with Brahms AG as lead sponsor.

NCT NCT01523717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Procalcitonin Decrease Over 72 Hours and Outcome in Patients With Severe Sepsis or Septic Shock
Lead sponsor
Brahms AG
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
March 31, 2014
Enrollment
858 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, severe sepsis